Effectiveness of prime vendor system on availability of medicines and medical supplies in the selected public health facilities in Arusha district council

被引:1
作者
Elias, Liberatus [1 ]
Mushi, Lawrencia [2 ]
机构
[1] Compass NFC Tanzania, Arusha, Tanzania
[2] Mzumbe Univ, Sch Publ Adm & Management, Dept Hlth Syst Management, Morogoro, Tanzania
关键词
Effectiveness; Prime vendor system; Prime vendor; Medicines; Medical supplies; Public health facilities;
D O I
10.1186/s12913-024-10581-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
IntroductionThe shortage of medicines and medical supplies remains to be a major issue that is facing public health facilities in Tanzania. This situation has been influenced by lack of consistency in the supply chain, increase in healthcare demand, poor regulatory system, insufficient funds, and lack of conducive infrastructure. Formerly, the Government initiatives such as engagement with the Prime Vendor System (PVS) demonstrated great assistance in getting rid of this challenge. Despite the operation of PVS, a recent shortage of medicines and medical supplies has been noticed.ObjectivesThis study aimed to assess the effectiveness of PVS on the availability of medicine and medical supplies in the selected public health facilities in Arusha District Council.MethodsThe study used a case study design with mixed research approach. The study involved 77 respondents which included 25 health facility in-charges, 50 patients, 1 District Pharmacist and 1 Prime Vendor. Questionnaires, interviews, and observation methods were used to collect data. Data collected covered a period of 2021-2022. Thematic analysis was used to analyze the qualitative data whereas descriptive analysis was used to analyze the quantitative data with the help of Excel and the Statistical Package for Social Sciences (SPSS) version 28.0.ResultsThe analysis indicates that PVS is not completely effective in supplying medicines and medical supplies due to its low capacity to conform to the orders placed by the public health facilities, a lack of supply competition, and a failure to adhere to contractual terms. Furthermore, at the time of data collection, the average availability of medicines and medical supplies at the selected public health facilities was 74.8%, while 80% of the selected public health facilities reported having a scarcity of medicines and medical supplies, and 92% of the interviewed patients reported having no full access to medicines.ConclusionDespite the shortcomings associated with the operation of the PVS, the system still seems to be very important for enhancing the availability of medicines and medical supplies once its effectiveness is strengthened. This study recommends a routine monitoring of PVS operations and timely interventions to reinforce an adherence to the contracted terms and improve PVS effectiveness.
引用
收藏
页数:9
相关论文
共 25 条
  • [1] Pharmacy Benefits Management in the Veterans Health Administration Revisited: A Decade of Advancements, 2004-2014
    Aspinall, Sherrie L.
    Sales, Mariscelle M.
    Good, Chester B.
    Calabrese, Vincent
    Glassman, Peter A.
    Burk, Muriel
    Moore, Von R.
    Neuhauser, Melinda M.
    Golterman, Lori
    Ourth, Heather
    Valentino, Michael A.
    Cunningham, Francesca E.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (09) : 1058 - 1063
  • [2] What impact does medicines shortages have on patients? A qualitative study exploring patients' experience and views of healthcare professionals
    Atif, Muhammad
    Sehar, Azka
    Malik, Iram
    Mushtaq, Irem
    Ahmad, Nafees
    Babar, Zaheer-Ud-Din
    [J]. BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [3] Medication supply chain resilience during disasters: exploration of causes, strategies, and consequences applying Strauss and Corbin's approach to the grounded theory
    Bastani, Peivand
    Sadeghkhani, Omid
    Bikine, Parisa
    Mehralian, Gholamhossein
    Samadbeik, Mahnaz
    Ravangard, Ramin
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [4] Access to medicines from a health system perspective
    Bigdeli, Maryam
    Jacobs, Bart
    Tomson, Goran
    Laing, Richard
    Ghaffar, Abdul
    Dujardin, Bruno
    Van Damme, Wim
    [J]. HEALTH POLICY AND PLANNING, 2013, 28 (07) : 692 - 704
  • [5] Edward Maluka O., 2021, Tanzan J Dev Stud, V19
  • [6] Erlangga H., 2022, Sys Rev Pharm 2020, V11, P617
  • [7] Promising Trends in Access to Medicines
    Gold, E. Richard
    Morin, Jean-Frederic
    [J]. GLOBAL POLICY, 2012, 3 (02) : 231 - 237
  • [8] Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology
    Kasonde, Lombe
    Tordrup, David
    Naheed, Aliya
    Zeng, Wu
    Ahmed, Shyfuddin
    Babar, Zaheer-Ud-Din
    [J]. BMC HEALTH SERVICES RESEARCH, 2019, 19 (1)
  • [9] Khalfan A, 2000, Research report series
  • [10] Knobler L, 2002, BIOLOGICAL THREATS T